Skip to content
  • Facebook
  • Twitter
This translation is automatically provided by Google; please refer to the original English version for appropriate wording.
Take on Typhoid

Take on Typhoid

  • Home
  • Why Typhoid?
    • Typhoid & Related Salmonelloses
    • Global Research
    • Links & Resources
  • The Issues
    • Vaccines
    • WASH
    • Drug-Resistant Typhoid
    • Treatment
    • Diagnostics
    • Typhoid intestinal perforation
    • Related Issues
  • Resources & Tools
    • Talk About Typhoid
    • Global Policy
    • Infographics
    • Fact Sheets
    • Share on Social
  • Blog & News
    • Blog
    • News
    • Publications
    • Newsletter
  • International Conference
    • Past Conferences
  • About Us
    • About the Coalition against Typhoid
    • About the Typhoid Vaccine Acceleration Consortium

Global Typhoid Vaccine Market 2018: Merck, GlaxoSmithKline, PaxVax, Actiza Pharmaceutical

Posted on November 20, 2018 by admin
  • The Typhoid Vaccine Market report highlights the current market size and future potential of the market at the global and regional level with the help of industry trends and market performance.

Post navigation

Superbugs: New strain of ‘highly’ drug resistant typhoid detected
Mystery fever in Balapur down to typhoid, dengue

Newsletter Signup

Recent Posts

  • PIT chez les enfants : comment les données chirurgicales et la surveillance orientent les priorités en matière de prévention

  • TIP in children: How surgical data and surveillance inform prevention priorities

  • Building a stronger market: The benefits of investing in more TCVs

  • Climate change and drug-resistant Salmonella

  • The economic burden of pediatric typhoid in Kenya: How illness drives costs for households and communities

cat
685 West Baltimore Street, Room 480
Baltimore, MD 21201-1509
Coalition against Typhoid
2000 Pennsylvania Ave, NW, Suite 7000
Washington, DC 20006
© 2018. Coalition Against Typhoid. All Rights Reserved.
  • Contact Us
  • Privacy Policy
  • Facebook
  • Twitter
Top